Literature DB >> 6721994

Urinary bile acid and bile alcohol excretion does not reflect the genetic polymorphism of debrisoquine hydroxylation.

G Karlaganis, A Küpfer, R Preisig.   

Abstract

Excretion of the major urinary bile alcohol 27-nor-5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24,25- pentol , and of cholic, chenodeoxycholic, deoxycholic and lithocholic acid was measured in 24 h urine collections of 10 extensive and seven poor metabolizers of debrisoquine. There was no significant difference of the excretion of these cholesterol metabolites between the two groups, indicating that cholesterol hydroxylation to bile alcohols and bile acids is probably not controlled by the same genes responsible for the 'debrisoquine-type' hydroxylation polymorphism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721994      PMCID: PMC1463396          DOI: 10.1111/j.1365-2125.1984.tb02374.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Protecting poor metabolizers, a group at high risk of adverse drug reactions.

Authors:  J R Idle; N S Oates; R R Shah; R L Smith
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

2.  Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection.

Authors:  M S Lennard; J H Silas; A J Smith; G T Tucker
Journal:  J Chromatogr       Date:  1977-03-11

3.  Hydroxylations in biosynthesis and metabolism of bile acids. Catalytic properties of different forms of cytochrome P-450.

Authors:  R Hansson; K Wikvall
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

Review 4.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine.

Authors:  B K Park; M Eichelbaum; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

Review 6.  Biochemistry of bile acids in health and disease.

Authors:  H Danielsson; J Gustafsson
Journal:  Pathobiol Annu       Date:  1981

7.  Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine.

Authors:  L Bertilsson; H J Dengler; M Eichelbaum; H U Schulz
Journal:  Eur J Clin Pharmacol       Date:  1980-02       Impact factor: 2.953

8.  Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry.

Authors:  B Almé; A Bremmelgaard; J Sjövall; P Thomassen
Journal:  J Lipid Res       Date:  1977-05       Impact factor: 5.922

9.  Polymorphic hydroxylation of Debrisoquine in man.

Authors:  A Mahgoub; J R Idle; L G Dring; R Lancaster; R L Smith
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

10.  [Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population].

Authors:  B Dick; A Küpfer; J Molnàr; S Braunschweig; R Preisig
Journal:  Schweiz Med Wochenschr       Date:  1982-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.